Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Introduction
- 1 Bipolar disorder in historical perspective
- 2 The bipolar spectrum
- 3 Defining and measuring Bipolar II Disorder
- 4 Bipolar II Disorder in context: epidemiology, disability and economic burden
- 5 Is Bipolar II Disorder increasing in prevalence?
- 6 The neurobiology of Bipolar II Disorder
- 7 The role of antidepressants in managing Bipolar II Disorder
- 8 The use of SSRIs as mood stabilisers for Bipolar II Disorder
- 9 Mood stabilisers in the treatment of Bipolar II Disorder
- 10 The use of atypical antipsychotic drugs in Bipolar II Disorder
- 11 The role of fish oil in managing Bipolar II Disorder
- 12 The role of psychological interventions in managing Bipolar II Disorder
- 13 The role of wellbeing plans in managing Bipolar II Disorder
- 14 Survival strategies for managing and prospering with Bipolar II Disorder
- 15 A clinical model for managing Bipolar II Disorder
- 16 Management commentary
- 17 Management commentary
- 18 Management commentary
- 19 Management commentary
- 20 Management commentary
- 21 Management commentary
- 22 Management commentary
- 23 Management commentary
- 24 Management commentary
- 25 Management commentary
- 26 Management commentary: What would Hippocrates do?
- 27 Management commentary
- 28 Rounding up and tying down
- Appendix 1 Black Dog Institute Self-test for Bipolar Disorder: The Mood Swings Questionnaire
- Index
- References
3 - Defining and measuring Bipolar II Disorder
Published online by Cambridge University Press: 13 August 2009
- Frontmatter
- Contents
- List of contributors
- Preface
- Introduction
- 1 Bipolar disorder in historical perspective
- 2 The bipolar spectrum
- 3 Defining and measuring Bipolar II Disorder
- 4 Bipolar II Disorder in context: epidemiology, disability and economic burden
- 5 Is Bipolar II Disorder increasing in prevalence?
- 6 The neurobiology of Bipolar II Disorder
- 7 The role of antidepressants in managing Bipolar II Disorder
- 8 The use of SSRIs as mood stabilisers for Bipolar II Disorder
- 9 Mood stabilisers in the treatment of Bipolar II Disorder
- 10 The use of atypical antipsychotic drugs in Bipolar II Disorder
- 11 The role of fish oil in managing Bipolar II Disorder
- 12 The role of psychological interventions in managing Bipolar II Disorder
- 13 The role of wellbeing plans in managing Bipolar II Disorder
- 14 Survival strategies for managing and prospering with Bipolar II Disorder
- 15 A clinical model for managing Bipolar II Disorder
- 16 Management commentary
- 17 Management commentary
- 18 Management commentary
- 19 Management commentary
- 20 Management commentary
- 21 Management commentary
- 22 Management commentary
- 23 Management commentary
- 24 Management commentary
- 25 Management commentary
- 26 Management commentary: What would Hippocrates do?
- 27 Management commentary
- 28 Rounding up and tying down
- Appendix 1 Black Dog Institute Self-test for Bipolar Disorder: The Mood Swings Questionnaire
- Index
- References
Summary
Introduction
In the last decade many commentators have stated that Bipolar II Disorder (BP II) is under-diagnosed. Over the same period, many others have stated that it is over-diagnosed. Such contradictory views hint at problems with definition and diagnosis – and reflect the controversy as to whether it is a true condition or more a personality style. As it is also commonly viewed as lying along a spectrum of mood disorders bounded by Bipolar I Disorder (BP I) and unipolar depressive conditions (see Chapter 2), we can assume that ‘boundary’ problems (in differentiating one condition clearly from the other) also contribute to difficulties in diagnostic delineation.
In Chapter 2, Phelps well argued the salience of a ‘spectrum’ model. In this chapter, an opposing categorical model is offered for consideration. This does reflect a personal view that bipolar disorder is a categorical condition or an ‘entity’, and further, that if distinctive sub-set diagnoses (of BP I and BP II) exist, distinction between them must be meaningful (in inferring differing clinical pictures and causes, and/or salient differential treatments). Medicine advanced by distinguishing differing clinicopathological expressions of the ‘pox’ (i.e. smallpox and chickenpox), differing causes of ‘dropsy’ (e.g. renal and cardiac) and in distinguishing Type I and Type II diabetes. All three examples (i.e. the ‘pox’, ‘dropsy’ and diabetes) could have been dimensionally modelled, but explanatory power would have been less, while aetiological and treatment implications would have been obscured.
- Type
- Chapter
- Information
- Bipolar II DisorderModelling, Measuring and Managing, pp. 46 - 60Publisher: Cambridge University PressPrint publication year: 2008
References
- 1
- Cited by